{"title":"男性生化复发和转移性前列腺癌的睾酮治疗:初步观察","authors":"A. Morgentaler, A. Abello, G. Bubley","doi":"10.1089/ANDRO.2021.0001","DOIUrl":null,"url":null,"abstract":"Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...","PeriodicalId":72197,"journal":{"name":"Androgens: clinical research and therapeutics","volume":"3 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations\",\"authors\":\"A. Morgentaler, A. Abello, G. Bubley\",\"doi\":\"10.1089/ANDRO.2021.0001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...\",\"PeriodicalId\":72197,\"journal\":{\"name\":\"Androgens: clinical research and therapeutics\",\"volume\":\"3 3\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Androgens: clinical research and therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ANDRO.2021.0001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Androgens: clinical research and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ANDRO.2021.0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Testosterone Therapy in Men with Biochemical Recurrence and Metastatic Prostate Cancer: Initial Observations
Introduction: Although prostate cancer (PCa) has long been considered an absolute contraindication for testosterone therapy (TTh), growing literature suggests TTh may be safely offered to men with ...
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
